Gilead Exercises Options to Three Arcus Biosciences Programs - MarketWatch

Retrieved on: 2021-11-18 15:46:24

Tags for this article:

Click the tags to see associated articles and topics

Gilead Exercises Options to Three Arcus Biosciences Programs - MarketWatch. View article details on hiswai:

Excerpt

Shares of Arcus, which closed Wednesday at $36.91, were recently up 14% in premarket trading. Write to Colin Kellaher at colin.kellaher@wsj.com. Read ...

Article found on: www.marketwatch.com

View Original Article